Alfred Tamayo, PhD

Senior Scientist, Pharmacology

Alfred is a molecular and cell biologist with a strong background in hands-on protein biochemistry, and brings his experience in a variety of disciplines to the team at Lytica Therapeutics. He is a former postdoctoral fellow of Massachusetts General Hospital/Shriners Hospital for Children and Harvard Medical School, where he helped develop novel cell and gene therapy prototypes, and elucidate mechanisms of transcription factor protein complexes critical to the circadian body clock respectively.  Alfred holds a bachelor's degree in biochemistry and molecular biology from Boston University, and received his Ph.D. from Boston University School of Medicine, where he studied membrane pore forming bacterial protein toxins, which are virulence factors for certain pathogens.